Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Inherited Retinal Disease > Pregnancy linked to increased risk of central vision loss in women with retinitis pigmentosa
  • Inherited Retinal Disease

Pregnancy linked to increased risk of central vision loss in women with retinitis pigmentosa

Kelsey Moroz

Women with USH2A-associated retinitis pigmentosa (RP) who have children are at a higher risk of experiencing significant central vision loss compared to women without children, according to a study. However, the study also found that pregnancy does not appear to accelerate retinal degeneration as measured by ellipsoid zone (EZ) loss.

The study included 142 women with biallelic rare or likely pathogenic variants in the USH2A gene, including 98 who had given birth (69%) and 44 who had never given birth (31%). Researchers analyzed visual acuity (VA), ellipsoid zone (EZ) width, and registration for sight impairment, adjusting for factors such as age, phenotype, cataracts, and cystoid macular oedema (CMO).

Parous women were 3.04 times more likely to have VA worse than LogMAR 0.7 (equivalent to 6/24 vision) compared to nulliparous women (P = 0.016). However, no significant association was found between pregnancy and EZ loss rate, a marker of retinal degeneration.

Parous women did not show higher rates of CMO or cataracts compared to nulliparous women.

This study is the first of its scale to evaluate pregnancy-related RP progression. Researchers emphasize the need for further studies to confirm these findings and explore underlying mechanisms.

Reference
Varela MD, Rashid M, Lopes A, et al. The effects of pregnancy on disease progression of retinitis pigmentosa. Am J Ophthalmol. 2024;S0002-9394(24)00548-8. doi: 10.1016/j.ajo.2024.11.016. Epub ahead of print. PMID: 39615819.

Share

Related Content

  • Inherited Retinal Disease

Patients with inherited retinal diseases face elevated risk of multiple ocular complications

  • Inherited Retinal Disease

Low-dose atropine shows limited effect on myopia progression in children with IRDs

  • Inherited Retinal Disease

Emerging imaging technologies offer hope for inherited retinal disease management

  • Inherited Retinal Disease

Emerging therapies and treatment for rare retinal diseases: a look at the pipeline

  • Inherited Retinal Disease

Breakthroughs in Gene Therapy and Diagnostics: Advancing Treatments and Understanding

  • Inherited Retinal Disease

Limited myopia progression in CSNB patients may guide treatment approaches

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon